Navigation Links
Healthcare Debate: One Citizen's Call for Calm Catches On
Date:9/2/2009

NEW YORK, Sept. 2 /PRNewswire/ -- In the midst of a tempestuous healthcare debate, one private citizen is proving you don't have to shout to be heard. A pioneer in the eHealth industry, Steve Parker, Jr., speaks with the calm voice of reason. His online call for a careful, strategic approach to reform is attracting the attention of business leaders inside and outside the healthcare industry, as well as everyday Americans currently struggling to pay their medical bills.

As an award-winning entrepreneur in the online healthcare industry and a lifelong advocate for affordable healthcare choices, Parker believes reform is a necessity. He speaks frankly about the shortcomings of the current system and offers strong criticism to presidential administrations past and present, as well as both major political parties. He also urges an end to the frantic rush in Washington to pass healthcare legislation that is neither understood nor understandable to the general public.

"Right now, there is no clearly defined plan to reform our nation's healthcare system. Instead, Congress has hastily combined an assortment of unconnected ideas and proposals into a massive reform bill," said Parker. "Sadly, this hurried approach is taking us in the wrong direction. It only complicates our muddled healthcare system further by introducing a number of unnecessary bureaucracies, unnecessary regulations, and unnecessary spending."

Parker's open message to Congress, the White House, and the American people can be found online at www.steveparkerjr.com.

And Parker is contributing more than just his voice to the ongoing debate. He is also opening his own wallet to ease the financial burden for ten American families currently suffering under the weight of their mounting medical bills. Ea
'/>"/>

SOURCE Steve M. Parker, Jr.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Obamas Specific Healthcare Speech: Will He Disavow Pledge-Breaking Tax Hikes in House Dem Health Bill?
2. Hologic to Present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference
3. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
4. SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program
5. BioMarin to Present at the Thomas Weisel Partners Healthcare Conference
6. Providence Service Corporation to Present at the Baird 2009 Healthcare Conference on September 9
7. DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
8. Derma Sciences To Present at Rodman & Renshaws Eleventh Annual Healthcare Conference
9. Transdel Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
10. MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
11. Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 1AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 1PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 2
Other Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10